» Articles » PMID: 31793867

Patient-reported Pain, Discomfort, and Anxiety During Magnetic Resonance Imaging-targeted Prostate Biopsy

Overview
Specialty Urology
Date 2019 Dec 4
PMID 31793867
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: The addition of targeted prostate biopsy to systemic biopsy impacts patient experience. We examined patient-reported pain, discomfort, anxiety, and tolerability among men undergoing magnetic resonance imaging (MRI)-targeted prostate biopsy in addition to transrectal ultrasound-guided systematic biopsy compared to those undergoing systematic biopsy alone.

Methods: All patients underwent transrectal systematic 14-core biopsies. Patients with regions of interest on MRI underwent additional targeted biopsies. All patients received equivalent periprostatic nerve block. Four single-item, standard, 11-point numerical rating scales evaluating pain, discomfort, anxiety, and tolerability were completed immediately after biopsy. Differences in means were compared using t-tests. Correlation between rated domains was tested using Spearman's correlation coefficient.

Results: Of 273 consecutive patients, 195 (71%) underwent targeted biopsy and 188 (69%) had undergone prior biopsy. In all men, the median score for pain and tolerability was 3, while the median score for discomfort and anxiety was 4. Pain was rated at 7 or above by 15% of patients. Moderate correlation between pain, discomfort, anxiety, and tolerability of repeat biopsy was observed (Spearman's ρ between 0.48 and 0.76). Compared to patients undergoing systematic biopsy alone, men who received both targeted and systematic biopsies reported higher anxiety scores (difference 1.2; 95% confidence interval [CI] 0.4-2.0; p=0.004) and discomfort (difference 1.0; 95% CI 0.3-1.7; p<0.001).

Conclusions: Patients undergoing targeted and systematic biopsies report more discomfort and anxiety than patients undergoing systematic biopsies alone. Absolute differences are small, and patients are willing to undergo repeat biopsy if advised. Interventions to reduce biopsy-related anxiety are needed.

Citing Articles

Risk Factors and Contemporary Management Options for Pain and Discomfort Experienced During a Prostate Biopsy.

Diaz G, Webb L, Rabil M, Lokeshwar S, Choksi A, Leapman M Curr Urol Rep. 2024; 25(10):243-252.

PMID: 38896314 DOI: 10.1007/s11934-024-01220-w.


Advanced prostate cancer diagnosed by bone metastasis biopsy immediately after initial negative prostate biopsy: a case report and literature review.

Liu M, Xie Z, Tang W, Liang G, Zhao Z, Wu T Front Oncol. 2024; 14:1365969.

PMID: 38800391 PMC: 11116681. DOI: 10.3389/fonc.2024.1365969.


Comparison of procedural anxiety and pain associated with conventional transrectal ultrasound prostate biopsy to magnetic resonance imaging-ultrasound fusion-guided biopsy: a prospective cohort trial.

Deivasigamani S, Adams E, Kotamarti S, Mottaghi M, Taha T, Aminsharifi A Prostate Cancer Prostatic Dis. 2023; 27(2):294-299.

PMID: 38001362 DOI: 10.1038/s41391-023-00760-5.


The Severity of Pain in Prostate Biopsy Depends on the Biopsy Sector.

Rempega G, Rajwa P, Kepinski M, Ryszawy J, Wojnarowicz J, Kowalik M J Pers Med. 2023; 13(3).

PMID: 36983612 PMC: 10057203. DOI: 10.3390/jpm13030431.


Prospective analysis of pain expectancy and experience during MR-fusion prostate biopsy: does reality match patients' expectancy?.

Krausewitz P, Schmeller H, Luetkens J, Dabir D, Ellinger J, Ritter M World J Urol. 2022; 40(9):2239-2244.

PMID: 35833972 PMC: 9427866. DOI: 10.1007/s00345-022-04083-3.


References
1.
Mkinen T, Auvinen A, Hakama M, Tammela T . Acceptability and complications of prostate biopsy in population-based PSA screening versus routine clinical practice: a prospective, controlled study. Urology. 2002; 60(5):846-50. DOI: 10.1016/s0090-4295(02)01864-2. View

2.
Robins D, Lipsky M, RoyChoudry A, Wenske S . Assessment of Discomfort and Pain in Patients Undergoing Fusion Magnetic Resonance Imaging-guided vs TRUS-guided Prostate Biopsy. Urology. 2018; 116:30-34. DOI: 10.1016/j.urology.2018.02.029. View

3.
Naughton C, Ornstein D, Smith D, Catalona W . Pain and morbidity of transrectal ultrasound guided prostate biopsy: a prospective randomized trial of 6 versus 12 cores. J Urol. 1999; 163(1):168-71. View

4.
Futterer J, Briganti A, De Visschere P, Emberton M, Giannarini G, Kirkham A . Can Clinically Significant Prostate Cancer Be Detected with Multiparametric Magnetic Resonance Imaging? A Systematic Review of the Literature. Eur Urol. 2015; 68(6):1045-53. DOI: 10.1016/j.eururo.2015.01.013. View

5.
Dworkin R, Turk D, Farrar J, Haythornthwaite J, Jensen M, Katz N . Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain. 2004; 113(1-2):9-19. DOI: 10.1016/j.pain.2004.09.012. View